Citations (129)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Jerome Egli, Stefan Heiler, Felix Weber, Guido Steiner, Timo Schwandt, Katharine Bray-French, Christian Klein, Sebastian Fenn, Gregor P. Lotz, Eugenia Opolka-Hoffmann, Thomas E. Kraft, Laetitia Petersen, Rebecca Moser, Jonathan DeGeer, Michel Siegel, Daniela Finke, Juliana Bessa & Antonio Iglesias. (2022) Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice. mAbs 14:1.
Read now
Read now
Michael J. Knight, Léontine Floret, Nisha Patel, John O’Hara & Elizabeth Rodriguez. (2022) The impact of forced degradation conditions on mAb dimer formation and subsequent influence on aggregation propensity. mAbs 14:1.
Read now
Read now
Marie R.G. Kopp, Adriana-Michelle Wolf Pérez, Marta Virginia Zucca, Umberto Capasso Palmiero, Brigitte Friedrichsen, Nikolai Lorenzen & Paolo Arosio. (2020) An accelerated surface-mediated stress assay of antibody instability for developability studies. mAbs 12:1.
Read now
Read now
Elsa Bodier-Montagutelli, Alexie Mayor, Laurent Vecellio, Renaud Respaud & Nathalie Heuzé-Vourc’h. (2018) Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?. Expert Opinion on Drug Delivery 15:8, pages 729-736.
Read now
Read now
Karthik Pisupati, Alexander Benet, Yuwei Tian, Solomon Okbazghi, Jukyung Kang, Michael Ford, Sergei Saveliev, K. Ilker Sen, Eric Carlson, Thomas J. Tolbert, Brandon T. Ruotolo, Steven P. Schwendeman & Anna Schwendeman. (2017) Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™. mAbs 9:7, pages 1197-1209.
Read now
Read now
Christine P. Chan. (2016) Forced degradation studies: current trends and future perspectives for protein-based therapeutics. Expert Review of Proteomics 13:7, pages 651-658.
Read now
Read now
Renaud Respaud, Laurent Vecellio, Patrice Diot & Nathalie Heuzé-Vourc’h. (2015) Nebulization as a delivery method for mAbs in respiratory diseases. Expert Opinion on Drug Delivery 12:6, pages 1027-1039.
Read now
Read now
Audrey E Baker, Amber R Mantz & Mark L Chiu. (2014) Raman spectroscopy characterization of antibody phases in serum. mAbs 6:6, pages 1509-1517.
Read now
Read now
Articles from other publishers (121)
Tjerk H Geersing, Dunja Dogan, M Reza Nejadnik, Stefan Romeijn, Catherijne A J Knibbe & Mirjam Crul. (2023) Aggregate Formation and Antibody Stability in Infusion Bags: The Impact of Manual and Robotic Compounding of Monoclonal Antibodies. Journal of Pharmaceutical Sciences.
Crossref
Crossref
Minoru Tada, Michihiko Aoyama & Akiko Ishii-Watabe. (2023) Target-independent Immune-cell Activation by Aggregates of T Cell-redirecting Bispecific Antibodies. Journal of Pharmaceutical Sciences 112:9, pages 2419-2426.
Crossref
Crossref
Md. Golam Kibria, Yukari Shiwaku, Subbaian Brindha & Yutaka Kuroda. (2023) Biophysical and biochemical nature of amorphous protein oligomers determines the strength of immune response and the generation of T‐cell memory. The FEBS Journal.
Crossref
Crossref
Petteri Heljo, Maryam Ahmadi, Malthe Møhl Hugo Schack, Robert Cunningham, Anaïs Manin, Per Franklin Nielsen, Xinsheng Tian, Mark Fogg, Campbell Bunce, Dorrit Baunsgaard & Wim Jiskoot. (2023) Impact of Stress on the Immunogenic Potential of Adalimumab. Journal of Pharmaceutical Sciences 112:4, pages 1000-1010.
Crossref
Crossref
Eduardo F. Mufarrege, Lucía C. Peña & Marina Etcheverrigaray. 2023. Antiviral Strategies in the Treatment of Human and Animal Viral Infections [Working Title]. Antiviral Strategies in the Treatment of Human and Animal Viral Infections [Working Title].
Camilla Thorlaksen, Heidi S. Schultz, Simon K. Gammelgaard, Wim Jiskoot, Nikos S. Hatzakis, Flemming S. Nielsen, Helene Solberg, Vito Foderà, Christina Bartholdy & Minna Groenning. (2023) In vitro and in vivo immunogenicity assessment of protein aggregate characteristics. International Journal of Pharmaceutics 631, pages 122490.
Crossref
Crossref
Mengqi Hu, Rosalynn Molden, Yunli Hu, Yu Huang, Haibo Qiu & Ning Li. (2022) Host cell protein identification in monoclonal antibody high molecular weight species. Journal of Chromatography B 1210, pages 123448.
Crossref
Crossref
Valentina Gusarova, Maxim Degterev, Ivan Lyagoskin, Vladimir Simonov, Maxim Smolov, Sergey Taran & Rahim Shukurov. (2022) Analytical and functional similarity of biosimilar Elizaria® with eculizumab reference product. Journal of Pharmaceutical and Biomedical Analysis 220, pages 115004.
Crossref
Crossref
Camilla Thorlaksen, Adriana-Maria Stanciu, Martin Busch Neergaard, Wim Jiskoot, Minna Groenning & Vito Foderà. (2022) Subtle pH variation around pH 4.0 affects aggregation kinetics and aggregate characteristics of recombinant human insulin. European Journal of Pharmaceutics and Biopharmaceutics 179, pages 166-172.
Crossref
Crossref
Camilla Thorlaksen, Adriana-Maria Stanciu, Martin Busch Neergaard, Nikos S. Hatzakis, Vito Foderà & Minna Groenning. (2022) Morphological integrity of insulin amyloid-like aggregates depends on preparation methods and post-production treatments. European Journal of Pharmaceutics and Biopharmaceutics 179, pages 147-155.
Crossref
Crossref
Yuan Du, Hongyi Wang, Yang Yang, Jianfeng Zhang, Yue Huang, Shunwu Fan, Chenhui Gu, Liqing Shangguan & Xianfeng Lin. (2022) Extracellular Vesicle Mimetics: Preparation from Top‐Down Approaches and Biological Functions. Advanced Healthcare Materials 11:19.
Crossref
Crossref
Tatiana Flisikowska, Jerome Egli, Krzysztof Flisikowski, Marlene Stumbaum, Erich Küng, Martin Ebeling, Roland Schmucki, Guy Georges, Thomas Singer, Mayuko Kurome, Barbara Kessler, Valeri Zakhartchenko, Eckhard Wolf, Felix Weber, Angelika Schnieke & Antonio Iglesias. (2022) A humanized minipig model for the toxicological testing of therapeutic recombinant antibodies. Nature Biomedical Engineering 6:11, pages 1248-1256.
Crossref
Crossref
Nam Ah Kim, Ga Yeon Noh, Shavron Hada, Kyung Jun Na, Hee-Jung Yoon, Ki-Woong Park, Young-Min Park & Seong Hoon Jeong. (2022) Enhanced protein aggregation suppressor activity of N-acetyl-l-arginine for agitation-induced aggregation with silicone oil and its impact on innate immune responses. International Journal of Biological Macromolecules 216, pages 42-51.
Crossref
Crossref
Elena K. Müller, Nataniel Białas, Matthias Epple & Ingrid Hilger. (2022) The Peptide/Antibody-Based Surface Decoration of Calcium Phosphate Nanoparticles Carrying siRNA Influences the p65 NF-κB Protein Expression in Inflamed Cells In Vitro. Biomedicines 10:7, pages 1571.
Crossref
Crossref
Alessandra Pistacchio, Fabio Baroni, Irene Cecchini, Roberta Verani, Mariano Stornaiuolo, Angelo Palmese & Carlo Pergola. (2022) Impact of four inorganic impurities – iron, copper, nickel and zinc - on the quality attributes of a Fc-fusion protein upon incubation at different temperatures. European Journal of Pharmaceutical Sciences 172, pages 106139.
Crossref
Crossref
Björn‐Hendrik Peters, James Bautista, Thomas R. Slaney, Hongyue Guo, Richard Y.‐C. Huang, Mary E. Krause, Ming Zeng, Julie Cheng & Zhi Chen. (2022) Enzymatic removal of sialic acid enables iCIEF stability monitoring of charge variants of a highly sialylated bispecific antibody. ELECTROPHORESIS 43:9-10, pages 1059-1067.
Crossref
Crossref
Joshua M. Tokuda, Jiansong Xie, Vibha Jawa, Jenn M. Hawkins, John Ferbas, Nathan H. Joh & Marisa K. Joubert. (2022) Use of In Vitro Human Skin Models to Assess Potential Immune Activation In Response to Biotherapeutic Attributes and Process-related Impurities. Journal of Pharmaceutical Sciences 111:4, pages 1012-1023.
Crossref
Crossref
Vaida Linkuvienė, Emma L. Ross, Lindsey Crawford, Sarah E. Weiser, Damen Man, Stephen Kay, Parag Kolhe & John F. Carpenter. (2022) Effects of Transportation of IV Bags Containing Protein Formulations Via Hospital Pneumatic Tube System: Particle Characterization by Multiple Methods. Journal of Pharmaceutical Sciences 111:4, pages 1024-1039.
Crossref
Crossref
Alexandra Roesch, Sarah Zölls, Daniela Stadler, Constanze Helbig, Klaus Wuchner, Gideon Kersten, Andrea Hawe, Wim Jiskoot & Tim Menzen. (2022) Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells. Journal of Pharmaceutical Sciences 111:4, pages 933-950.
Crossref
Crossref
Surbhi Gupta, Wim Jiskoot, Christian Schöneich & Anurag S. Rathore. (2022) Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy. Journal of Pharmaceutical Sciences 111:4, pages 903-918.
Crossref
Crossref
Sharif Hasan Siddiqui, Mousumee Khan, Darae Kang, Hyun Woo Choi & Kwanseob Shim. (2022) Meta-Analysis and Systematic Review of the Thermal Stress Response: Gallus gallus domesticus Show Low Immune Responses During Heat Stress. Frontiers in Physiology 13.
Crossref
Crossref
Michihiko Aoyama, Minoru Tada, Hidetomo Yokoo, Yosuke Demizu & Akiko Ishii-Watabe. (2021) Fcγ Receptor-Dependent Internalization and Off-Target Cytotoxicity of Antibody-Drug Conjugate Aggregates. Pharmaceutical Research 39:1, pages 89-103.
Crossref
Crossref
Yukako Senga, Toshihiko Ogura, Hiroshi Imamura & Shinya Honda. 2022. Therapeutic Antibodies. Therapeutic Antibodies
219
239
.
Shravan Sreenivasan, Wim Jiskoot & Anurag S. Rathore. (2021) Rapid aggregation of therapeutic monoclonal antibodies by bubbling induced air/liquid interfacial and agitation stress at different conditions. European Journal of Pharmaceutics and Biopharmaceutics 168, pages 97-109.
Crossref
Crossref
Shravan Sreenivasan, Deepak Sonawat & Anurag S. Rathore. (2021) Image Analysis Algorithm-Based Platform for Determining Micron and Higher Aggregate Size Distribution of Therapeutic IgG Using Brightfield and Fluorescence Microscope Images. Pharmaceutical Research 38:10, pages 1747-1763.
Crossref
Crossref
Ravindra Kumar, Asya V. Grinberg, Huiming Li, Tzu-Hsing Kuo, Dianne Sako, Lavanya Krishnan, Katia Liharska, Jia Li, Rosa Grenha, Michelle C. Maguire, Steven D. Briscoe, R. Scott Pearsall, Brantley R. Herrin, Rajasekhar N. V. S. Suragani & Roselyne Castonguay. (2021) Functionally diverse heteromeric traps for ligands of the transforming growth factor-β superfamily. Scientific Reports 11:1.
Crossref
Crossref
Christian Schöneich. (2021) Photo-induced fragmentation of tyrosine side chains in IgG4-Fc: Effect of protein sequence, conformation and glycan structure. Journal of Photochemistry and Photobiology 7, pages 100049.
Crossref
Crossref
Mimmi L. E. Lundahl, Silvia Fogli, Paula E. Colavita & Eoin M. Scanlan. (2021) Aggregation of protein therapeutics enhances their immunogenicity: causes and mitigation strategies. RSC Chemical Biology 2:4, pages 1004-1020.
Crossref
Crossref
Neha N. Pardeshi, Maryam Ahmadi, Izabela Sierzputowska, Mark Fogg, Matthew Baker & John F. Carpenter. (2021) Subvisible Particles in Solutions of Remicade in Intravenous Saline Activate Immune System Pathways in In Vitro Human Cell Systems. Journal of Pharmaceutical Sciences 110:8, pages 2894-2903.
Crossref
Crossref
Md. Golam Kibria, Yoko Akazawa-Ogawa, Yoshihisa Hagihara & Yutaka Kuroda. (2021) Immune response with long-term memory triggered by amorphous aggregates of misfolded anti-EGFR VHH-7D12 is directed against the native VHH-7D12 as well as the framework of the analogous VHH-9G8. European Journal of Pharmaceutics and Biopharmaceutics 165, pages 13-21.
Crossref
Crossref
Maxwell Korang-Yeboah, Stephanie Ketcham, Mack Shih, Ann-Marie Ako-Adounvo, Jinhui Zhang, Bandaranayake M. Bandaranayake, Yvonne Abbey-Berko, Patrick Faustino & Muhammad Ashraf. (2021) Effect of formulation and peptide folding on the fibrillar aggregation, gelation, and oxidation of a therapeutic peptide. International Journal of Pharmaceutics 604, pages 120677.
Crossref
Crossref
Jared A. Delmar, Eugen Buehler, Ashwin K. Chetty, Agastya Das, Guillermo Miro Quesada, Jihong Wang & Xiaoyu Chen. (2021) Machine learning prediction of methionine and tryptophan photooxidation susceptibility. Molecular Therapy - Methods & Clinical Development 21, pages 466-477.
Crossref
Crossref
Yi Wen & Vibha Jawa. (2021) The Impact of Product and Process Related Critical Quality Attributes on Immunogenicity and Adverse Immunological Effects of Biotherapeutics. Journal of Pharmaceutical Sciences 110:3, pages 1025-1041.
Crossref
Crossref
Nicole L. Jarvi & Sathy V. Balu-Iyer. (2021) Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins. BioDrugs 35:2, pages 125-146.
Crossref
Crossref
Adam Grabarek, Myriam Nabhan, Isabelle Turbica, Andrea Hawe, Marc Pallardy & Wim Jiskoot. (2021) Immunological Evaluation In Vitro of Nanoparticulate Impurities Isolated From Pharmaceutical-Grade Sucrose. Journal of Pharmaceutical Sciences 110:2, pages 952-958.
Crossref
Crossref
Lowell J. Brady. 2021. Monoclonal Antibodies. Monoclonal Antibodies
121
159
.
Neil Brewis. 2021. Introduction to Antibody Engineering. Introduction to Antibody Engineering
303
317
.
Abigail A. Matthews, Pui Lai Rachel Ee & Ruowen Ge. (2020) Developing inhaled protein therapeutics for lung diseases. Molecular Biomedicine 1:1.
Crossref
Crossref
Julia Gross-Rother, Michaela Blech, Eduard Preis, Udo Bakowsky & Patrick Garidel. (2020) Particle Detection and Characterization for Biopharmaceutical Applications: Current Principles of Established and Alternative Techniques. Pharmaceutics 12:11, pages 1112.
Crossref
Crossref
Myriam Nabhan, François-Xavier Legrand, Victor Le-Minh, Baptiste Robin, Rami Bechara, Nicolas Huang, Claire Smadja, Marc Pallardy & Isabelle Turbica. (2020) The FcγRIIa–Syk Axis Controls Human Dendritic Cell Activation and T Cell Response Induced by Infliximab Aggregates. The Journal of Immunology 205:9, pages 2351-2361.
Crossref
Crossref
Michael Ulitzka, Stefania Carrara, Julius Grzeschik, Henri Kornmann, Björn Hock & Harald Kolmar. (2020) Engineering therapeutic antibodies for patient safety: tackling the immunogenicity problem. Protein Engineering, Design and Selection 33.
Crossref
Crossref
Rohit Bansal, Rozaleen Dash & Anurag S. Rathore. (2020) Impact of mAb Aggregation on Its Biological Activity: Rituximab as a Case Study. Journal of Pharmaceutical Sciences 109:9, pages 2684-2698.
Crossref
Crossref
Christoph Grapentin, Claudia Müller, Ravuri S.K. Kishore, Michael Adler, Inas ElBialy, Wolfgang Friess, Jörg Huwyler & Tarik A. Khan. (2020) Protein-Polydimethylsiloxane Particles in Liquid Vial Monoclonal Antibody Formulations Containing Poloxamer 188. Journal of Pharmaceutical Sciences 109:8, pages 2393-2404.
Crossref
Crossref
Md. Golam Kibria, Yoko Akazawa-Ogawa, Nafsoon Rahman, Yoshihisa Hagihara & Yutaka Kuroda. (2020) The immunogenicity of an anti-EGFR single domain antibody (VHH) is enhanced by misfolded amorphous aggregation but not by heat-induced aggregation. European Journal of Pharmaceutics and Biopharmaceutics 152, pages 164-174.
Crossref
Crossref
Nafsoon Rahman, Mohammad Monirul Islam, Satoru Unzai, Shiho Miura & Yutaka Kuroda. (2020)
Nanometer-Sized Aggregates Generated Using Short Solubility Controlling Peptide Tags Do Increase the
In Vivo
Immunogenicity of a Nonimmunogenic Protein
. Molecular Pharmaceutics 17:5, pages 1629-1637.
Crossref
Crossref
Jun-Jie Huang, Xiang-Ning Li, Wan-Li Liu, Han-Ye Yuan, Yuan Gao, Kan Wang, Bo Tang, Dai-Wen Pang, Jie Chen & Yi Liang. (2020) Neutralizing Mutations Significantly Inhibit Amyloid Formation by Human Prion Protein and Decrease Its Cytotoxicity. Journal of Molecular Biology 432:4, pages 828-844.
Crossref
Crossref
Christine Siska, Paul Harber & Bruce A. Kerwin. (2020) Shocking Data on Parcel Shipments of Protein Solutions. Journal of Pharmaceutical Sciences 109:1, pages 690-695.
Crossref
Crossref
Ruben Wälchli, Pieter-Jan Vermeire, Jan Massant & Paolo Arosio. (2020) Accelerated Aggregation Studies of Monoclonal Antibodies: Considerations for Storage Stability. Journal of Pharmaceutical Sciences 109:1, pages 595-602.
Crossref
Crossref
Minoru Tada, Michihiko Aoyama & Akiko Ishii-Watabe. (2020) Fcγ Receptor Activation by Human Monoclonal Antibody Aggregates. Journal of Pharmaceutical Sciences 109:1, pages 576-583.
Crossref
Crossref
Yoann Le Basle, Philip Chennell, Nicolas Tokhadze, Alain Astier & Valérie Sautou. (2020) Physicochemical Stability of Monoclonal Antibodies: A Review. Journal of Pharmaceutical Sciences 109:1, pages 169-190.
Crossref
Crossref
Grzegorz Kijanka, Jared S. Bee, Mark A. Schenerman, Samuel A. Korman, Yuling Wu, Bram Slütter & Wim Jiskoot. (2020) Monoclonal Antibody Dimers Induced by Low pH, Heat, or Light Exposure Are Not Immunogenic Upon Subcutaneous Administration in a Mouse Model. Journal of Pharmaceutical Sciences 109:1, pages 730-738.
Crossref
Crossref
Andrea Hawe, Daniel Weinbuch, Sarah Zölls, Angelika Reichel & John F. Carpenter. 2020. Biophysical Characterization of Proteins in Developing Biopharmaceuticals. Biophysical Characterization of Proteins in Developing Biopharmaceuticals
285
310
.
Steven Messick, Miguel Saggu & Anacelia Ríos Quiroz. 2020. Development of Biopharmaceutical Drug-Device Products. Development of Biopharmaceutical Drug-Device Products
251
264
.
Malthe Møhl Schack, Kevin Dahl, Thomas Rades, Minna Groenning & John F. Carpenter. (2019) Spectroscopic Evidence of Tertiary Structural Differences Between Insulin Molecules in Fibrils. Journal of Pharmaceutical Sciences 108:9, pages 2871-2879.
Crossref
Crossref
Teresa Kraus, Annika Lubitz, Ulrike Schließer, Christoph Giese, Jana Reuschel, René Brecht, Julia Engert & Gerhard Winter. (2019) Evaluation of a 3D Human Artificial Lymph Node as Test Model for the Assessment of Immunogenicity of Protein Aggregates. Journal of Pharmaceutical Sciences 108:7, pages 2358-2366.
Crossref
Crossref
Yukako Senga, Hiroshi Imamura, Toshihiko Ogura & Shinya Honda. (2019) In-Solution Microscopic Imaging of Fractal Aggregates of a Stressed Therapeutic Antibody. Analytical Chemistry 91:7, pages 4640-4648.
Crossref
Crossref
Erik Doevendans & Huub Schellekens. (2019) Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies. Antibodies 8:1, pages 21.
Crossref
Crossref
Malthe Møhl Schack, Eva Horn Møller, Anders V. Friderichsen, John F. Carpenter, Thomas Rades & Minna Groenning. (2019) Optimization of Infrared Microscopy to Assess Secondary Structure of Insulin Molecules Within Individual Subvisible Particles in Aqueous Formulations. Journal of Pharmaceutical Sciences 108:3, pages 1117-1129.
Crossref
Crossref
Teresa Kraus, Gerhard Winter & Julia Engert. (2019) Test models for the evaluation of immunogenicity of protein aggregates. International Journal of Pharmaceutics 559, pages 192-200.
Crossref
Crossref
Grzegorz Kijanka, Jared S. Bee, Samuel A. Korman, Yuling Wu, Lorin K. Roskos, Mark A. Schenerman, Bram Slütter & Wim Jiskoot. (2018) Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice. Journal of Pharmaceutical Sciences 107:11, pages 2847-2859.
Crossref
Crossref
Yukako Senga & Shinya Honda. (2018) Suppression of Aggregation of Therapeutic Monoclonal Antibodies during Storage by Removal of Aggregation Precursors Using a Specific Adsorbent of Non-Native IgG Conformers. Bioconjugate Chemistry 29:10, pages 3250-3261.
Crossref
Crossref
Yi Yang, Anna Mah, Inn H. Yuk, Parbir S. Grewal, Abigail Pynn, Will Cole, Di Gao, Fan Zhang, Jia Chen, Lynn Gennaro & Christian Schöneich. (2018) Investigation of Metal-Catalyzed Antibody Carbonylation With an Improved Protein Carbonylation Assay. Journal of Pharmaceutical Sciences 107:10, pages 2570-2580.
Crossref
Crossref
Wei Wang & Christopher J. Roberts. (2018) Protein aggregation – Mechanisms, detection, and control. International Journal of Pharmaceutics 550:1-2, pages 251-268.
Crossref
Crossref
Yeon Woong Choo, Mikyung Kang, Han Young Kim, Jin Han, Seokyung Kang, Ju-Ro Lee, Gun-Jae Jeong, Sung Pil Kwon, Seuk Young Song, Seokhyeong Go, Mungyo Jung, Jihye Hong & Byung-Soo Kim. (2018) M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors. ACS Nano 12:9, pages 8977-8993.
Crossref
Crossref
Stanley Chung, Jun Tian, Zhijun Tan, Jie Chen, Jongchan Lee, Michael Borys & Zheng Jian Li. (2018) Industrial bioprocessing perspectives on managing therapeutic protein charge variant profiles. Biotechnology and Bioengineering 115:7, pages 1646-1665.
Crossref
Crossref
Tiina Reinivuori, Pekka Kurki & Paul Chamberlain. (2018) Immunogenicity Assessment of Biosimilars. Pharmaceutical Medicine 32:2, pages 103-121.
Crossref
Crossref
Ming Lei, Cynthia Quan, Y. John Wang, Yung-Hsiang Kao & Christian Schöneich. (2018) Light-Induced Covalent Buffer Adducts to Histidine in a Model Protein. Pharmaceutical Research 35:3.
Crossref
Crossref
N. D. Vlieland, M. R. Nejadnik, H. Gardarsdottir, S. Romeijn, A. S. Sediq, M. L. Bouvy, A. C. G. Egberts, B. J. F. van den Bemt & W. Jiskoot. (2018) The Impact of Inadequate Temperature Storage Conditions on Aggregate and Particle Formation in Drugs Containing Tumor Necrosis Factor-Alpha Inhibitors. Pharmaceutical Research 35:2.
Crossref
Crossref
Aaron B. Krueger & Matthew D. Brown. 2018. Biosimilars. Biosimilars
363
391
.
Hanns-Christian Mahler & Anja Matter. 2018. Challenges in Protein Product Development. Challenges in Protein Product Development
125
137
.
Daniel Weinbuch, Mitchel Ruigrok, Wim Jiskoot & Andrea Hawe. (2017) Nanoparticulate Impurities Isolated from Pharmaceutical-Grade Sucrose Are a Potential Threat to Protein Stability. Pharmaceutical Research 34:12, pages 2910-2921.
Crossref
Crossref
Sumit K. Singh, Deepak Kumar & Anurag S. Rathore. (2017) Determination of Critical Quality Attributes for a Biotherapeutic in the QbD Paradigm: GCSF as a Case Study. The AAPS Journal 19:6, pages 1826-1841.
Crossref
Crossref
Lora Hamuro, Grzegorz Kijanka, Francis Kinderman, Harald Kropshofer, De-xiu Bu, Monica Zepeda & Vibha Jawa. (2017) Perspectives on Subcutaneous Route of Administration as an Immunogenicity Risk Factor for Therapeutic Proteins. Journal of Pharmaceutical Sciences 106:10, pages 2946-2954.
Crossref
Crossref
Yukako Senga, Hiroshi Imamura, Takamitsu Miyafusa, Hideki Watanabe & Shinya Honda. (2017) AlphaScreen-based homogeneous assay using a pair of 25-residue artificial proteins for high-throughput analysis of non-native IgG. Scientific Reports 7:1.
Crossref
Crossref
Tomonobu Uchino, Yasunori Miyazaki, Takuto Yamazaki & Yoshiyuki Kagawa. (2017) Immunogenicity of protein aggregates of a monoclonal antibody generated by forced shaking stress with siliconized and nonsiliconized syringes in BALB/c mice. Journal of Pharmacy and Pharmacology 69:10, pages 1341-1351.
Crossref
Crossref
Hiroshi Imamura, Akira Sasaki & Shinya Honda. (2017) Fate of a Stressed Therapeutic Antibody Tracked by Fluorescence Correlation Spectroscopy: Folded Monomers Survive Aggregation. The Journal of Physical Chemistry B 121:34, pages 8085-8093.
Crossref
Crossref
Ohseok Kwon, Jeewon Joung, Younjoo Park, Chan Wha Kim & Seung Hwa Hong. (2017) Considerations of critical quality attributes in the analytical comparability assessment of biosimilar products. Biologicals 48, pages 101-108.
Crossref
Crossref
Carly F. Chisholm, Kaitlin R. Soucie, Jane S. Song, Pamela Strauch, Raul M. Torres, John F. Carpenter, Jack A. Ragheb & Theodore W. Randolph. (2017) Immunogenicity of Structurally Perturbed Hen Egg Lysozyme Adsorbed to Silicone Oil Microdroplets in Wild-Type and Transgenic Mouse Models. Journal of Pharmaceutical Sciences 106:6, pages 1519-1527.
Crossref
Crossref
Marc J. Pallardy, Isabelle Turbica & Armelle Biola-Vidamment. (2017) Why the Immune System Should Be Concerned by Nanomaterials?. Frontiers in Immunology 8.
Crossref
Crossref
Nathaniel R. Maddux, Austin L. Daniels & Theodore W. Randolph. (2017) Microflow Imaging Analyses Reflect Mechanisms of Aggregate Formation: Comparing Protein Particle Data Sets Using the Kullback–Leibler Divergence. Journal of Pharmaceutical Sciences 106:5, pages 1239-1248.
Crossref
Crossref
Björn Boll, Juliana Bessa, Emilien Folzer, Anacelia Ríos Quiroz, Roland Schmidt, Patrick Bulau, Christof Finkler, Hanns-Christian Mahler, Jörg Huwyler, Antonio Iglesias & Atanas V. Koulov. (2017) Extensive Chemical Modifications in the Primary Protein Structure of IgG1 Subvisible Particles Are Necessary for Breaking Immune Tolerance. Molecular Pharmaceutics 14:4, pages 1292-1299.
Crossref
Crossref
Yann Gallais, Natacha Szely, François‐Xavier Legrand, Arnaud Leroy, Marc Pallardy & Isabelle Turbica. (2016) Effect of growth hormone and IgG aggregates on dendritic cells activation and T‐cells polarization. Immunology & Cell Biology 95:3, pages 306-315.
Crossref
Crossref
J. Benjamin St. Clair, Thiago Detanico, Katja Aviszus, Greg A. Kirchenbaum, Merry Christie, John F. Carpenter & Lawrence J. Wysocki. (2017) Immunogenicity of Isogenic IgG in Aggregates and Immune Complexes. PLOS ONE 12:1, pages e0170556.
Crossref
Crossref
Roy Jefferis. 2021. Advances in Glycobiotechnology. Advances in Glycobiotechnology
281
318
.
Xinsheng Tian, M. Reza Nejadnik, Dorrit Baunsgaard, Anette Henriksen, Christian Rischel & Wim Jiskoot. (2016) A Comprehensive Evaluation of Nanoparticle Tracking Analysis (NanoSight) for Characterization of Proteinaceous Submicron Particles. Journal of Pharmaceutical Sciences 105:11, pages 3366-3375.
Crossref
Crossref
Hideki Watanabe, Seiki Yageta, Hiroshi Imamura & Shinya Honda. (2016) Biosensing Probe for Quality Control Monitoring of the Structural Integrity of Therapeutic Antibodies. Analytical Chemistry 88:20, pages 10095-10101.
Crossref
Crossref
Lucas Wafer, Marek Kloczewiak & Yin Luo. (2016) Quantifying Trace Amounts of Aggregates in Biopharmaceuticals Using Analytical Ultracentrifugation Sedimentation Velocity: Bayesian Analyses and F Statistics. The AAPS Journal 18:4, pages 849-860.
Crossref
Crossref
E. M. Moussa, J. Kotarek, J. S. Blum, E. Marszal & E. M. Topp. (2016) Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model. Pharmaceutical Research 33:7, pages 1736-1751.
Crossref
Crossref
Wim Jiskoot, Grzegorz Kijanka, Theodore W. Randolph, John F. Carpenter, Atanas V. Koulov, Hanns-Christian Mahler, Marisa K. Joubert, Vibha Jawa & Linda O. Narhi. (2016) Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges. Journal of Pharmaceutical Sciences 105:5, pages 1567-1575.
Crossref
Crossref
Saba Ghazvini, Cavan Kalonia, David B. Volkin & Prajnaparamita Dhar. (2016) Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb. Journal of Pharmaceutical Sciences 105:5, pages 1643-1656.
Crossref
Crossref
Olivier Mozziconacci, Jayant Arora, Ronald T. TothIVIV, Sangeeta B. Joshi, Shuxia Zhou, David B. Volkin & Christian Schöneich. (2016) Site-Specific Hydrolysis Reaction C-Terminal of Methionine in Met-His during Metal-Catalyzed Oxidation of IgG-1. Molecular Pharmaceutics 13:4, pages 1317-1328.
Crossref
Crossref
Dean C. Ripple & Zhishang Hu. (2015) Correcting the Relative Bias of Light Obscuration and Flow Imaging Particle Counters. Pharmaceutical Research 33:3, pages 653-672.
Crossref
Crossref
Ehab M. Moussa, Jainik P. Panchal, Balakrishnan S. Moorthy, Janice S. Blum, Marisa K. Joubert, Linda O. Narhi & Elizabeth M. Topp. (2016) Immunogenicity of Therapeutic Protein Aggregates. Journal of Pharmaceutical Sciences 105:2, pages 417-430.
Crossref
Crossref
Harald Kropshofer & Wolfgang F. Richter. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
12
.
L Andrews, S Ralston, E Blomme & K Barnhart. (2015) A snapshot of biologic drug development. Human & Experimental Toxicology 34:12, pages 1279-1285.
Crossref
Crossref
Merry Christie, David Peritt, Raul M. Torres, Theodore W. Randolph & John F. Carpenter. (2015) The Role of Protein Excipient in Driving Antibody Responses to Erythropoietin. Journal of Pharmaceutical Sciences 104:12, pages 4041-4055.
Crossref
Crossref
Vincent Corvari, Linda O. Narhi, Thomas M. Spitznagel, Nataliya Afonina, Shawn Cao, Patricia Cash, Irene Cecchini, Michael R. DeFelippis, Patrick Garidel, Andrea Herre, Atanas V. Koulov, Tony Lubiniecki, Hanns-Christian Mahler, Paolo Mangiagalli, Douglas Nesta, Bernardo Perez-Ramirez, Alla Polozova, Mara Rossi, Roland Schmidt, Robert Simler, Satish Singh, Andrew Weiskopf & Klaus Wuchner. (2015) Subvisible (2–100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis. Biologicals 43:6, pages 457-473.
Crossref
Crossref
Daniel Weinbuch, Jason K. Cheung, Jurgen Ketelaars, Vasco Filipe, Andrea Hawe, John den Engelsman & Wim Jiskoot. (2015) Nanoparticulate Impurities in Pharmaceutical-Grade Sugars and their Interference with Light Scattering-Based Analysis of Protein Formulations. Pharmaceutical Research 32:7, pages 2419-2427.
Crossref
Crossref
Juliana Bessa, Sabine Boeckle, Hermann Beck, Thomas Buckel, Sonja Schlicht, Martin Ebeling, Anna Kiialainen, Atanas Koulov, Björn Boll, Thomas Weiser, Thomas Singer, Antonius G. Rolink & Antonio Iglesias. (2015) The Immunogenicity of Antibody Aggregates in a Novel Transgenic Mouse Model. Pharmaceutical Research 32:7, pages 2344-2359.
Crossref
Crossref
Liusong Yin, Xiaoying Chen, Paolo Vicini, Bonita Rup & Timothy P. Hickling. (2015) Therapeutic outcomes, assessments, risk factors and mitigation efforts of immunogenicity of therapeutic protein products. Cellular Immunology 295:2, pages 118-126.
Crossref
Crossref
Linda O. Narhi, Vincent Corvari, Dean C. Ripple, Nataliya Afonina, Irene Cecchini, Michael R. Defelippis, Patrick Garidel, Andrea Herre, Atanas V. Koulov, Tony Lubiniecki, Hanns-Christian Mahler, Paolo Mangiagalli, Douglas Nesta, Bernardo Perez-Ramirez, Alla Polozova, Mara Rossi, Roland Schmidt, Robert Simler, Satish Singh, Thomas M. Spitznagel, Andrew Weiskopf & Klaus Wuchner. (2015) Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy. Journal of Pharmaceutical Sciences 104:6, pages 1899-1908.
Crossref
Crossref
Maliheh Shomali, Sultan Tanriverdi, Angelika J. Freitag, Julia Engert, Gerhard Winter, Michael Siedler, Zehra Kaymakcalan, John F. Carpenter & Theodore W. Randolph. (2015) Dose Levels in Particulate-Containing Formulations Impact Anti-drug Antibody Responses to Murine Monoclonal Antibody in Mice. Journal of Pharmaceutical Sciences 104:5, pages 1610-1621.
Crossref
Crossref
Srivalli Telikepalli, Heather E. Shinogle, Prem S. Thapa, Jae Hyun Kim, Meghana Deshpande, Vibha Jawa, C. Russell Middaugh, Linda O. Narhi, Marisa K. Joubert & David B. Volkin. (2015) Physical Characterization and In Vitro Biological Impact of Highly Aggregated Antibodies Separated into Size-Enriched Populations by Fluorescence-Activated Cell Sorting. Journal of Pharmaceutical Sciences 104:5, pages 1575-1591.
Crossref
Crossref
Maryam Ahmadi, Christine J. Bryson, Edward A. Cloake, Katie Welch, Vasco Filipe, Stefan Romeijn, Andrea Hawe, Wim Jiskoot, Matthew P. Baker & Mark H. Fogg. (2014) Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics. Pharmaceutical Research 32:4, pages 1383-1394.
Crossref
Crossref
Shinichiro Totoki, Gaku Yamamoto, Kouhei Tsumoto, Susumu Uchiyama & Kiichi Fukui. (2015) Quantitative Laser Diffraction Method for the Assessment of Protein Subvisible Particles. Journal of Pharmaceutical Sciences 104:2, pages 618-626.
Crossref
Crossref
Liusong Yin, Xiaoying Chen, Abhinav Tiwari, Paolo Vicini & Timothy P. Hickling. (2015) The Role of Aggregates of Therapeutic Protein Products in Immunogenicity: An Evaluation by Mathematical Modeling. Journal of Immunology Research 2015, pages 1-14.
Crossref
Crossref
Andrea Hawe, Sarah Zölls, Angelika Freitag & John F. Carpenter. 2015. Biophysical Characterization of Proteins in Developing Biopharmaceuticals. Biophysical Characterization of Proteins in Developing Biopharmaceuticals
261
286
.
O. Nuchuchua, H.A. Every, G.W. Hofland & W. Jiskoot. (2014) Scalable organic solvent free supercritical fluid spray drying process for producing dry protein formulations. European Journal of Pharmaceutics and Biopharmaceutics 88:3, pages 919-930.
Crossref
Crossref
Subhashchandra Naik, Ozan S. Kumru, Melissa Cullom, Srivalli N. Telikepalli, Elizabeth Lindboe, Taylor L. Roop, Sangeeta B. Joshi, Divya Amin, Phillip Gao, C. Russell Middaugh, David B. Volkin & Mark T. Fisher. (2014) Probing structurally altered and aggregated states of therapeutically relevant proteins using GroEL coupled to bio-layer interferometry. Protein Science 23:10, pages 1461-1478.
Crossref
Crossref
Riccardo Torosantucci, Vera Brinks, Grzegorz Kijanka, Liem Andhyk Halim, Melody Sauerborn, Huub Schellekens & Wim Jiskoot. (2014) Development of a Transgenic Mouse Model to Study the Immunogenicity of Recombinant Human Insulin. Journal of Pharmaceutical Sciences 103:5, pages 1367-1374.
Crossref
Crossref
Riccardo Torosantucci, Christian Schöneich & Wim Jiskoot. (2013) Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences. Pharmaceutical Research 31:3, pages 541-553.
Crossref
Crossref
Srivalli N. Telikepalli, Ozan S. Kumru, Cavan Kalonia, Reza Esfandiary, Sangeeta B. Joshi, C. Russell Middaugh & David B. Volkin. (2014) Structural Characterization of IgG1 mAb Aggregates and Particles Generated Under Various Stress Conditions. Journal of Pharmaceutical Sciences 103:3, pages 796-809.
Crossref
Crossref
Vasco Filipe, Ivo Que, John F. Carpenter, Clemens Löwik & Wim Jiskoot. (2013) In Vivo Fluorescence Imaging of IgG1 Aggregates After Subcutaneous and Intravenous Injection in Mice. Pharmaceutical Research 31:1, pages 216-227.
Crossref
Crossref
Sven Kronenberg, Andreas Baumann, Lolke de Haan, Heather J. Hinton, Jonathan Moggs, Frank-Peter Theil, Ian Wakefield & Thomas Singer. (2013) Current challenges and opportunities in nonclinical safety testing of biologics. Drug Discovery Today 18:23-24, pages 1138-1143.
Crossref
Crossref
Cavan Kalonia, Ozan S. Kumru, Jae Hyun Kim, C. Russell Middaugh & David B. Volkin. (2013) Radar Chart Array Analysis to Visualize Effects of Formulation Variables on IgG1 Particle Formation as Measured by Multiple Analytical Techniques. Journal of Pharmaceutical Sciences 102:12, pages 4256-4267.
Crossref
Crossref
Vivian Bi, Vibha Jawa, Marisa K. Joubert, Arunan Kaliyaperumal, Catherine Eakin, Karen Richmond, Oscar Pan, Jilin Sun, Martha Hokom, Theresa J. Goletz, Jette Wypych, Lei Zhou, Bruce A. Kerwin, Linda O. Narhi & Taruna Arora. (2013) Development of a Human Antibody Tolerant Mouse Model to Assess the Immunogenicity Risk Due to Aggregated Biotherapeutics. Journal of Pharmaceutical Sciences 102:10, pages 3545-3555.
Crossref
Crossref
Vasco Filipe, Andrea Hawe, John F. Carpenter & Wim Jiskoot. (2013) Analytical approaches to assess the degradation of therapeutic proteins. TrAC Trends in Analytical Chemistry 49, pages 118-125.
Crossref
Crossref
Riccardo Torosantucci, Daniel Weinbuch, Robin Klem & Wim Jiskoot. (2013) Triethylenetetramine prevents insulin aggregation and fragmentation during copper catalyzed oxidation. European Journal of Pharmaceutics and Biopharmaceutics 84:3, pages 464-471.
Crossref
Crossref
Riccardo Torosantucci, Victor S. Sharov, Miranda van Beers, Vera Brinks, Christian Schöneich & Wim Jiskoot. (2013) Identification of Oxidation Sites and Covalent Cross-Links in Metal Catalyzed Oxidized Interferon Beta-1a: Potential Implications for Protein Aggregation and Immunogenicity. Molecular Pharmaceutics 10:6, pages 2311-2322.
Crossref
Crossref
Ranajoy Majumdar, Prakash Manikwar, John M. Hickey, Hardeep S. Samra, Hasige A. Sathish, Steven M. Bishop, C. Russell Middaugh, David B. Volkin & David D. Weis. (2013) Effects of Salts from the Hofmeister Series on the Conformational Stability, Aggregation Propensity, and Local Flexibility of an IgG1 Monoclonal Antibody. Biochemistry 52:19, pages 3376-3389.
Crossref
Crossref
Camilla Thorlaksen, Adriana-Maria Stanciu, Martin Busch Neergaard, Wim Jiskoot, Minna Groenning & Vito Foderà. (2022) Subtle Ph Variation Close to Pi Affects Aggregation Pathway, Formation Kinetics and Aggregate Characteristics of Recombinant Human Insulin. SSRN Electronic Journal.
Crossref
Crossref